Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells $76,450.53 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,873 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $76,450.53. Following the sale, the chief operating officer now directly owns 779,993 shares of the company’s stock, valued at approximately $20,755,613.73. This trade represents a 0.37 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total transaction of $38,758.29.

Phreesia Trading Down 5.9 %

NYSE PHR opened at $26.75 on Friday. The company’s fifty day moving average price is $22.87 and its two-hundred day moving average price is $22.62. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of -18.20 and a beta of 0.94. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.16. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.58) earnings per share. As a group, research analysts predict that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in the business. International Assets Investment Management LLC lifted its holdings in shares of Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after purchasing an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp bought a new stake in Phreesia in the second quarter worth $202,000. Point72 DIFC Ltd bought a new position in Phreesia during the second quarter valued at about $209,000. XTX Topco Ltd bought a new stake in Phreesia during the third quarter worth approximately $247,000. Finally, Hsbc Holdings PLC acquired a new position in Phreesia during the second quarter valued at approximately $301,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PHR has been the subject of several recent research reports. KeyCorp increased their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research report on Friday. Citigroup upped their target price on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their target price for the company from $24.00 to $32.00 in a report on Wednesday. Finally, Truist Financial upped their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.